Severe COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia or Indolent B-Cell Non-Hodgkin Lymphoma Who Received Pre-Exposure Prophylaxis with Tixagevimab and Cilgavimab in Italy: Preliminary Results of the Observational Study By the Gimema Working Party on Chronic Lymphoproliferative Disorders and By the Fondazione Italiana Linfomi
Gian Matteo Rigolin, Antonio Cuneo(University of Ferrara), Paola Fazi(Fondazione Gimema Onlus), Marina Motta(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Emanuela Sant’Antonio(IRCCS Ospedale San Raffaele), Rossella Riccioni(Ospedale di Livorno), Francesca Romana Mauro(Sapienza University of Rome), Attilio Olivieri(Ospedali Riuniti di Ancona), Marina Deodato(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Riccardo Moia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Lydia Scarfò(IRCCS Ospedale San Raffaele), Guido Gini(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Marika Porrazzo(Ospedale Vincenzo Cervello), Andrea Mengarelli(Istituti di Ricovero e Cura a Carattere Scientifico), Martina Tomassi(Istituti Fisioterapici Ospitalieri), Alfonso Piciocchi(Fondazione Gimema Onlus), Pellegrino Musto(University of Bari Aldo Moro), Annamaria Giordano(University of Bari Aldo Moro), Antonio Urso(Arcispedale Sant'Anna), Anna Maria Frustaci(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Caterina Patti(Ospedale Vincenzo Cervello), Giulia Daghia(University of Ferrara), Ilaria Scortechini(Azienda Ospedaliero-Universitaria delle Marche), Riccardo Dondolin(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Paolo Ghia(Vita-Salute San Raffaele University), Alessandro Sanna(Agence Régionale de Santé Nouvelle-Aquitaine), Stefano Soddu(Fondazione Gimema Onlus), Sara Martinelli(University of Ferrara), Clara Virginia Vigano'(Alessandro Manzoni Hospital), Francesca Paoloni(Fondazione Gimema Onlus), Antonella Anastasia(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Sara Pepe(Sapienza University of Rome)
Cited by 0
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k